Literature DB >> 20655566

Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implications.

Tiyun Wu1, Siddhartha A K Datta, Mithun Mitra, Robert J Gorelick, Alan Rein, Judith G Levin.   

Abstract

The HIV-1 Gag polyprotein precursor has multiple domains including nucleocapsid (NC). Although mature NC and NC embedded in Gag are nucleic acid chaperones (proteins that remodel nucleic acid structure), few studies include detailed analysis of the chaperone activity of partially processed Gag proteins and comparison with NC and Gag. Here we address this issue by using a reconstituted minus-strand transfer system. NC and NC-containing Gag proteins exhibited annealing and duplex destabilizing activities required for strand transfer. Surprisingly, unlike NC, with increasing concentrations, Gag proteins drastically inhibited the DNA elongation step. This result is consistent with "nucleic acid-driven multimerization" of Gag and the reported slow dissociation of Gag from bound nucleic acid, which prevent reverse transcriptase from traversing the template ("roadblock" mechanism). Our findings illustrate one reason why NC (and not Gag) has evolved as a critical cofactor in reverse transcription, a paradigm that might also extend to other retrovirus systems. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655566      PMCID: PMC2963451          DOI: 10.1016/j.virol.2010.06.042

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  77 in total

1.  Molecular recognition in the HIV-1 capsid/cyclophilin A complex.

Authors:  S Yoo; D G Myszka; C Yeh; M McMurray; C P Hill; W I Sundquist
Journal:  J Mol Biol       Date:  1997-06-27       Impact factor: 5.469

2.  Rapid kinetics of protein-nucleic acid interaction is a major component of HIV-1 nucleocapsid protein's nucleic acid chaperone function.

Authors:  Margareta Cruceanu; Robert J Gorelick; Karin Musier-Forsyth; Ioulia Rouzina; Mark C Williams
Journal:  J Mol Biol       Date:  2006-08-30       Impact factor: 5.469

3.  Conformation of the HIV-1 Gag protein in solution.

Authors:  Siddhartha A K Datta; Joseph E Curtis; William Ratcliff; Patrick K Clark; Rachael M Crist; Jacob Lebowitz; Susan Krueger; Alan Rein
Journal:  J Mol Biol       Date:  2006-10-26       Impact factor: 5.469

4.  Roles of the human immunodeficiency virus type 1 nucleocapsid protein in annealing and initiation versus elongation in reverse transcription of viral negative-strand strong-stop DNA.

Authors:  L Rong; C Liang; M Hsu; L Kleiman; P Petitjean; H de Rocquigny; B P Roques; M A Wainberg
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 5.  Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication.

Authors:  A Rein; L E Henderson; J G Levin
Journal:  Trends Biochem Sci       Date:  1998-08       Impact factor: 13.807

6.  Compensatory point mutations in the human immunodeficiency virus type 1 Gag region that are distal from deletion mutations in the dimerization initiation site can restore viral replication.

Authors:  C Liang; L Rong; M Laughrea; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 7.  HIV-1 gag proteins: diverse functions in the virus life cycle.

Authors:  E O Freed
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

8.  Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein.

Authors:  T R Gamble; S Yoo; F F Vajdos; U K von Schwedler; D K Worthylake; H Wang; J P McCutcheon; W I Sundquist; C P Hill
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

9.  Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly.

Authors:  U K von Schwedler; T L Stemmler; V Y Klishko; S Li; K H Albertine; D R Davis; W I Sundquist
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

10.  Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch.

Authors:  Siddhartha A K Datta; Zhuojun Zhao; Patrick K Clark; Sergey Tarasov; Jerry N Alexandratos; Stephen J Campbell; Mamuka Kvaratskhelia; Jacob Lebowitz; Alan Rein
Journal:  J Mol Biol       Date:  2006-10-26       Impact factor: 5.469

View more
  32 in total

Review 1.  Nucleic acid chaperone activity of retroviral Gag proteins.

Authors:  Alan Rein
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 2.  Features, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function.

Authors:  Gilles Mirambeau; Sébastien Lyonnais; Robert J Gorelick
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 3.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

4.  Selection of fully processed HIV-1 nucleocapsid protein is required for optimal nucleic acid chaperone activity in reverse transcription.

Authors:  Tiyun Wu; Robert J Gorelick; Judith G Levin
Journal:  Virus Res       Date:  2014-06-20       Impact factor: 3.303

Review 5.  Diverse interactions of retroviral Gag proteins with RNAs.

Authors:  Alan Rein; Siddhartha A K Datta; Christopher P Jones; Karin Musier-Forsyth
Journal:  Trends Biochem Sci       Date:  2011-05-06       Impact factor: 13.807

6.  HIV-1 Pr55Gag binds genomic and spliced RNAs with different affinity and stoichiometry.

Authors:  Serena Bernacchi; Ekram W Abd El-Wahab; Noé Dubois; Marcel Hijnen; Redmond P Smyth; Johnson Mak; Roland Marquet; Jean-Christophe Paillart
Journal:  RNA Biol       Date:  2016-11-14       Impact factor: 4.652

7.  The C-terminal p6 domain of the HIV-1 Pr55Gag precursor is required for specific binding to the genomic RNA.

Authors:  Noé Dubois; Keith K Khoo; Shannon Ghossein; Tanja Seissler; Philippe Wolff; William J McKinstry; Johnson Mak; Jean-Christophe Paillart; Roland Marquet; Serena Bernacchi
Journal:  RNA Biol       Date:  2018-08-04       Impact factor: 4.652

8.  Zinc finger function of HIV-1 nucleocapsid protein is required for removal of 5'-terminal genomic RNA fragments: a paradigm for RNA removal reactions in HIV-1 reverse transcription.

Authors:  Christopher B Hergott; Mithun Mitra; Jianhui Guo; Tiyun Wu; Jennifer T Miller; Yasumasa Iwatani; Robert J Gorelick; Judith G Levin
Journal:  Virus Res       Date:  2012-11-10       Impact factor: 3.303

9.  Role of the SP2 domain and its proteolytic cleavage in HIV-1 structural maturation and infectivity.

Authors:  Alex de Marco; Anke-Mareil Heuser; Bärbel Glass; Hans-Georg Kräusslich; Barbara Müller; John A G Briggs
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

10.  Nucleocapsid Protein Precursors NCp9 and NCp15 Suppress ATP-Mediated Rescue of AZT-Terminated Primers by HIV-1 Reverse Transcriptase.

Authors:  Moisés A Árquez; Samara Martín-Alonso; Robert J Gorelick; Walter A Scott; Antonio J Acosta-Hoyos; Luis Menéndez-Arias
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.